Magneto-sensitive liposomes can be obtained by encapsulation of magnetic nanoparticles into liposomes or by the coverage of magnetic nanoparticles with a lipid bilayer. The so-called magnetoliposomes make possible to explore the synergistic effect between chemotherapy and magnetic hyperthermia in cancer therapeutics. Both aqueous magnetoliposomes (magnetic nanoparticles entrapped in liposomes) and solid magnetoliposomes (clusters of nanoparticles covered by a lipid bilayer), containing biocompatible magnetic nanoparticles, have been developed, exhibiting a superparamagnetic behavior and diameters below 150 nm. These nanosystems were successfully tested as nanocarriers for fluorescent potential antitumor drugs. Drug-loaded magnetoliposomes have shown the ability to interact by fusion with models of biomembranes and to release the antitumor drugs in in vitro assays using human tumor cell lines. Fluorescencebased methodologies, including Förster Resonance Energy Transfer (FRET), emission quenching and fluorescence anisotropy, have been used as valuable tools for this investigation.
Access to the requested content is limited to institutions that have purchased or subscribe to SPIE eBooks.
You are receiving this notice because your organization may not have SPIE eBooks access.*
*Shibboleth/Open Athens users─please
sign in
to access your institution's subscriptions.
To obtain this item, you may purchase the complete book in print or electronic format on
SPIE.org.
INSTITUTIONAL Select your institution to access the SPIE Digital Library.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.